Private Market View

Laboratoire POLIDIS

Rueil-Malmaison, France · Founded 1986 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include UI Investissement, Siparex.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 2 names
  • ·Watchlist + deal alerts for Laboratoire POLIDIS
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Laboratoire POLIDIS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Laboratoire POLIDIS

Manufacturer of medical devices based in Rueil-Malmaison. The company offers products including condoms, pregnancy tests, ovulation tests, pain relieving gels, food supplements and other related products, thereby offering effective, user-friendly products, adapted to professionals and accessible to individuals.

Sector
Business Products and Services (B2B)
HQ
Rueil-Malmaison, France
Founded
1986
Employees
18
Ownership
Privately Held (backing)
PA Mark — not yet priced

Laboratoire POLIDIS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Laboratoire POLIDIS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Laboratoire POLIDIS in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.